Fortis Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,800
Closed -$581K 128
2025
Q2
$581K Hold
3,800
0.37% 52
2025
Q1
$630K Buy
3,800
+56
+1% +$8.76K 0.41% 46
2024
Q4
$542K Sell
3,744
-532
-12% -$82.4K 0.36% 51
2024
Q3
$693K Hold
4,276
0.45% 41
2024
Q2
$625K Hold
4,276
0.44% 37
2024
Q1
$676K Hold
4,276
0.45% 38
2023
Q4
$670K Hold
4,276
0.48% 36
2023
Q3
$666K Buy
4,276
+708
+20% +$117K 0.5% 36
2023
Q2
$591K Sell
3,568
-770
-18% -$124K 0.42% 35
2023
Q1
$672K Hold
4,338
0.44% 32
2022
Q4
$766K Buy
4,338
+543
+14% +$93.8K 0.58% 28
2022
Q3
$620K Buy
3,795
+13
+0.3% +$2.2K 0.44% 38
2022
Q2
$671K Buy
3,782
+11
+0.3% +$1.96K 0.44% 36
2022
Q1
$668K Buy
3,771
+11
+0.3% +$1.87K 0.37% 42
2021
Q4
$643K Buy
3,760
+12
+0.3% +$1.97K 0.37% 41
2021
Q3
$605K Sell
3,748
-489
-12% -$83.4K 0.37% 43
2021
Q2
$698K Sell
4,237
-703
-14% -$116K 0.4% 46
2021
Q1
$812K Buy
4,940
+460
+10% +$74.4K 0.58% 37
2020
Q4
$705K Buy
4,480
+40
+0.9% +$5.9K 0.62% 26
2020
Q3
$661K Hold
4,440
0.62% 25
2020
Q2
$624K Hold
4,440
0.62% 28
2020
Q1
$582K Sell
4,440
-1,815
-29% -$258K 0.39% 32
2019
Q4
$912K Hold
6,255
0.55% 30
2019
Q3
$809K Hold
6,255
0.38% 31
2019
Q2
$871K Hold
6,255
0.42% 31
2019
Q1
$874K Hold
6,255
0.46% 29
2018
Q4
$807K Hold
6,255
0.49% 27
2018
Q3
$864K Sell
6,255
-116
-2% -$15.4K 0.49% 30
2018
Q2
$771K Hold
6,371
0.44% 30
2018
Q1
$817K Hold
6,371
0.45% 27
2017
Q4
$890K Sell
6,371
-46
-0.7% -$6.41K 0.55% 21
2017
Q3
$834K Sell
6,417
-713
-10% -$94.5K 0.58% 22
2017
Q2
$944K Hold
7,130
0.73% 19
2017
Q1
$888K Buy
7,130
+4,383
+160% +$524K 0.81% 19
2016
Q4
$317K Buy
+2,747
New +$317K 0.34% 22

Other funds holding JNJ

Fortis Advisors's JNJ Position: Q3 2025 in Review

Fortis Advisors sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 3,800 shares — an estimated $581K sold.

Fortis Advisors first reported a position in JNJ in Q4 2016 and held it in 35 quarters. The position peaked at $944K in Q2 2017. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Fortis Advisors reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Fortis Advisors sold 3,800 Johnson & Johnson shares in Q3 2025, an estimated $581K.
  • Fortis Advisors first reported a position in Johnson & Johnson in Q4 2016 and held it in 35 quarters.
  • Fortis Advisors's Johnson & Johnson position peaked at $944K in Q2 2017.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Fortis Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.